Dare Bioscience, Inc. Shareholders' Equity
Dare Bioscience, Inc. (DARE) had Shareholders' Equity of -$560.10 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent -$560.10K.
- 2026-03-31: Stockholders' Equity Attributable to Parent $734.45K.
- 2025-12-31: Stockholders' Equity Attributable to Parent $2.84M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $2.86M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$560.10K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $734.45K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $2.84M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $2.86M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$12.73M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | -$9.56M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | -$6.01M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | -$1.48M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $2.67M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | -$11.00M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | -$5.05M 10-K · filed 2026-03-26 | |
| 2023-09-30 | -$2.29M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$2.72M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $4.97M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $11.11M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $26.34M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $33.03M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $30.88M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $38.75M 10-K · filed 2024-03-28 | |
| 2021-09-30 | $31.89M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $7.74M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $3.26M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | -$1.15M 10-K · filed 2023-03-30 | |
| 2020-09-30 | -$1.39M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $311.25K 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $3.21M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $440.83K 10-K · filed 2022-03-31 | |
| 2019-09-30 | $1.81M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $5.08M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $3.78M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $6.73M 10-K · filed 2021-03-30 | |
| 2018-09-30 | $9.58M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $12.22M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $15.82M 10-Q · filed 2019-08-14 | |
| 2017-12-31 | $13.29M 10-K · filed 2020-03-27 | |
| 2017-09-30 | $22.43M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | -$1.45M 8-K/A · filed 2017-10-02 | $4.06M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $7.74M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | -$710.62K 10-K · filed 2019-04-01 | $13.11M 10-K · filed 2017-03-31 |
| 2016-09-30 | $16.62M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $25.84M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $35.98M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | -$46.95K 10-K · filed 2018-03-28 | $48.74M 10-K · filed 2016-03-10 |
| 2015-09-30 | $58.64M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $68.20M 10-Q · filed 2015-08-06 | |
| 2015-05-28 | $0.00 8-K/A · filed 2017-10-02 | |
| 2015-03-31 | $40.41M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $45.33M 10-K/A · filed 2017-06-13 | |
| 2014-09-30 | $52.53M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $57.81M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | -$97.04M 10-Q · filed 2014-05-27 | |
| 2013-12-31 | -$94.30M 10-K/A · filed 2017-06-13 | |
| 2012-12-31 | -$80.04M 10-K · filed 2016-03-10 | |
| 2011-12-31 | -$58.40M 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |